82 related articles for article (PubMed ID: 25299561)
1. Fatal sepsis after intravesical instillation of BCG: case report.
Andrade E Silva UV; Viana Lde S; Oliveira E Castro Pde T; Almeida RD; Silva RS
Rev Bras Ter Intensiva; 2011 Mar; 23(1):104-7. PubMed ID: 25299561
[TBL] [Abstract][Full Text] [Related]
2. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
Yumura Y; Oogo Y; Takase K; Hamano A; Yamashita Y; Noguchi S; Satomi Y
Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
[TBL] [Abstract][Full Text] [Related]
3. Adverse drug reactions of intravesical bacillus Calmette-Guerin instillation and risk factors of the development of adverse drug reactions in superficial cancer and carcinoma in situ of the bladder.
Koga H; Kuroda M; Kudo S; Yamaguchi A; Usami M; Suzuki T; Naito S
Int J Urol; 2005 Feb; 12(2):145-51. PubMed ID: 15733108
[TBL] [Abstract][Full Text] [Related]
4. [Bacillus Calmette-Guerin intravesical instillation treatment for carcinoma in situ of the bladder. Gifu BCG Instillation Therapy Research Group].
Nishino Y; Yasuda M; Yokoi S; Ehara H; Yamamoto N; Takahashi Y; Ishihara S; Deguchi T; Kawada Y; Takeda A; Sakai S; Takeuchi T; Taniguchi M; Minoshima K; Hamamoto Y; Kanimoto Y; Nakano M; Fujihiro S; Nezasa S; Matsuda T; Nagatani Y; Maeda S; Tamaki M; Saito A; Komeda H
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1869-73. PubMed ID: 10560414
[TBL] [Abstract][Full Text] [Related]
5. [Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer].
Yi SH; Ye G; Wang XW; Jin HS; Zhang YN; Yan ZL
Ai Zheng; 2008 Nov; 27(11):1208-11. PubMed ID: 19000455
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Steroid Pulse Therapy for Systemic Side Effects after Bacillus Calmette-Guérin Intravesical Instillation Therapy: A Series of Five Cases.
Umemoto T; Naruse J; Usui Y; Zakoji H; Miyakita H; Miyajima A
Case Rep Urol; 2021; 2021():5548054. PubMed ID: 34336352
[TBL] [Abstract][Full Text] [Related]
7. Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.
Giannarini G; Birkhäuser FD; Recker F; Thalmann GN; Studer UE
Eur Urol; 2014 Apr; 65(4):825-31. PubMed ID: 24144432
[TBL] [Abstract][Full Text] [Related]
8. Urinary Interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin.
Thalmann GN; Sermier A; Rentsch C; Möhrle K; Cecchini MG; Studer UE
J Urol; 2000 Dec; 164(6):2129-33. PubMed ID: 11061941
[TBL] [Abstract][Full Text] [Related]
9. [Effect of prophylactic intravesical instillation of BCG for superficial bladder cancer].
Segawa N; Inamoto T; Nomi H; Ibuki N; Azuma H; Katsuoka Y
Hinyokika Kiyo; 2009 Apr; 55(4):175-80. PubMed ID: 19462820
[TBL] [Abstract][Full Text] [Related]
10. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J
Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510
[TBL] [Abstract][Full Text] [Related]
11. [Multiorgan failure following intravesical bacillus Calmette-Guerin administration: a case report].
Baba Y; Ishizu K; Jojima K; Joko K; Nakamura K; Takihara H; Naito K
Hinyokika Kiyo; 1992 Sep; 38(9):1063-5. PubMed ID: 1414761
[TBL] [Abstract][Full Text] [Related]
12. Intravesical valrubicin in patients with bladder carcinoma in situ and contraindication to or failure after bacillus Calmette-Guérin.
Dinney CP; Greenberg RE; Steinberg GD
Urol Oncol; 2013 Nov; 31(8):1635-42. PubMed ID: 22575238
[TBL] [Abstract][Full Text] [Related]
13. [Intravesical BCG therapy for superficial bladder cancer].
Segawa N; Iwamoto Y; Azuma H; Yamamoto K; Ueda H; Katsuoka Y
Hinyokika Kiyo; 1998 Sep; 44(9):627-31. PubMed ID: 9805666
[TBL] [Abstract][Full Text] [Related]
14. [Two cases of successful treatments with steroid for local and systemic hypersensitivity reaction following intravesical instillation of Bacillus Calmette-Guerin].
Shimasaki N; Yamasaki I; Kamada M; Syuin T
Hinyokika Kiyo; 2001 Apr; 47(4):281-4. PubMed ID: 11411106
[TBL] [Abstract][Full Text] [Related]
15. Intravesical instillation therapy with bacillus Calmette-Guérin for superficial bladder cancer: study of the mechanism of bacillus Calmette-Guérin immunotherapy.
Shintani Y; Sawada Y; Inagaki T; Kohjimoto Y; Uekado Y; Shinka T
Int J Urol; 2007 Feb; 14(2):140-6. PubMed ID: 17302571
[TBL] [Abstract][Full Text] [Related]
16. A Case of Epididymo-orchitis after intravesical bacille Calmette-Guérin therapy for superficial bladder carcinoma in a patient with latent tuberculosis infection.
Colomba C; Di Carlo P; Guadagnino G; Siracusa L; Trizzino M; Gioè C; Cascio A
Infect Agent Cancer; 2016; 11():25. PubMed ID: 27257433
[TBL] [Abstract][Full Text] [Related]
17. [Intravesical bacillus Calmette-Guerin instillation therapy of recurrent superficial bladder carcinomas resistant to intravesical anti-cancer chemotherapy].
Takeuchi S; Kihara K; Higashi Y; Fukui I; Oshima H
Hinyokika Kiyo; 1989 Apr; 35(4):577-81. PubMed ID: 2735262
[TBL] [Abstract][Full Text] [Related]
18. Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Guérin immunotherapy for carcinoma in situ of the bladder.
Watanabe E; Matsuyama H; Matsuda K; Ohmi C; Tei Y; Yoshihiro S; Ohmoto Y; Naito K
Cancer Immunol Immunother; 2003 Aug; 52(8):481-6. PubMed ID: 12707736
[TBL] [Abstract][Full Text] [Related]
19. Disseminated Bacillus Calmette-Guérin (BCG) infection presenting as severe respiratory failure and septic shock.
Marouli D; Pappas C; Raissaki M; Proklou A; Papadakis E; Kondili E
Germs; 2023 Sep; 13(3):277-281. PubMed ID: 38146386
[TBL] [Abstract][Full Text] [Related]
20. Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Instillation for the Treatment of Superficial Transitional Cell Carcinoma of the Bladder.
Elzein F; Albogami N; Saad M; El Tayeb N; Alghamdi A; Elyamany G
Clin Med Insights Case Rep; 2016; 9():71-3. PubMed ID: 27559301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]